ArticleTrials2020

Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial.

Bangjiang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.